Q1 Earnings Estimate for SYRE Issued By Leerink Partnrs
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Spyre Therapeutics in a report issued on Tuesday, April 8th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings of ($0.83) per share for the quarter. Leerink Partnrs […]
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Spyre Therapeutics in a report issued on Tuesday, April 8th. Leerink Partnrs analyst F. Khurshid forecasts that the company will post earnings of ($0.83) per share for the quarter. Leerink Partnrs […]
